The TOGETHER Trial is a clinical trial platform evaluating repurposed drugs for early treatment of COVID-19. The TOGETHER Trial's aim is to discover if existing medications can be used to treat people with early-diagnosed COVID-19.
The TOGETHER Trial was initiated on June of 2020. On January 20, 2021, TOGETHER enrolled its first patient.
The TOGETHER Trial is a multi-platform, randomized, adaptive trial. The co-principal investigators of TOGETHER are Dr. Edward Mills and Dr. Gilmar Reis.
Links
- togethertrial.com - website for the TOGETHER trial. Includes trial protocol design, statistical analysis plan and other information.
- TOGETHER Trial on Twitter.